Jannah Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.
Business

Ekosi Health partners with Cerebra to evaluate the efficacy of clinical cannabinoid therapy on sleep quality. Canadian Business Journal

GIMLI, Manitoba, Nov. 8, 2022 (GLOBE NEWSWIRE) — Ekosi Health, a Canada-based Indigenous-owned healthcare provider specializing in clinical cannabinoid therapies, has entered into an alliance with leading sleep technology company Cerebra. announced a partnership. Observational studies evaluating the effectiveness of cannabinoid therapy on sleep quality. Considered to be the first study in the field, Cerebra’s sleep system and proprietary Odd Ratio Product (ORP) Sleep Depth Index were used in participants’ homes to objectively assess the effectiveness of cannabinoid therapy. is comfortably used.

With over 27,000 patient interactions, Ekosi Health has successfully improved conditions ranging from chronic pain to substance abuse. Although some preliminary evidence points to a positive impact on sleep improvement from cannabinoid therapy, mixed results still highlight the need for groundbreaking and further research. uses a patented algorithm, the Odds Ratio Product (ORP), to micro-analyze electroencephalogram (EEG) signals to provide a continuous measure of sleep depth, going beyond traditional scoring methods. We dig deeper into our activities,” explains Dr. Amy Bender, Director of Clinical Sleep Science at Cerebra.

The origins of the observational study came as a result of the Manitoba Bioscience Association’s Advancing Healthcare Initiative (AHI), funded by Prairies Economic Development Canada. The initiative was designed to connect healthcare innovators and clinicians to evaluate and support the real-world application and evaluation of innovators’ technologies, and to foster collaborations like Ekosi Health and Cerebra. “Ekosi Health’s mission is to improve the quality of life of individuals seeking knowledge and safe access to cannabis and other plant-based medicines. We will provide an innovative, personalized experience for participants who seek it,” said Dr. Shelley Turner, Chief Medical Officer, Ekosi Health.

After completing the observational study, Ekosi Health and Cerebra expect to expand their partnership to generate additional valuable insights into cannabinoid therapy and sleep research.

About Ecosi Health

Ekosi Health is Canada’s leading Indigenous-owned provider of quality healthcare. By maximizing the use of research findings and strictly adhering to internally developed practices and procedures, Ekosi Health delivers a harmonized, reduction-oriented, innovative and personalized healthcare experience that enables individuals to: Helping you become the best version of yourself possible.

To learn more about how Ekosi Health helps individuals and improves communities, visit ekosihealth.com.

About Cerebra

Cerebra Medical Ltd. is a Canadian technology company transforming the future of sleep diagnostics and therapy. Cerebra unites innovators and researchers with a shared goal and passion to bring sleep back to sleep medicine.

The Cerebra Sleep System uses a patented algorithm, Odds Ratio Product (ORP), to micro-analyze electroencephalogram (EEG) signals to provide a continuous measure of sleep depth, going beyond traditional scoring methods. to dig deeper into brain activity. As the leader in sleep diagnostic technology, our revolutionary Cerebra Sleep System provides sleep researchers and clinicians with accurate, self-applicable at-home diagnostics.


CBJ Newsmaker

Ekosi Health partners with Cerebra to evaluate the efficacy of clinical cannabinoid therapy on sleep quality. Canadian Business Journal

Source link Ekosi Health partners with Cerebra to evaluate the efficacy of clinical cannabinoid therapy on sleep quality. Canadian Business Journal

Related Articles

Back to top button